NCT04893798View on ClinicalTrials.gov

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 24, 2025

Study Completion Date

July 24, 2025

Conditions
Healthy
Interventions
COMBINATION_PRODUCT

Sayana Press

Sayana Press is a drug-device combination and is considered a medical product in the EU.

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04893798 - A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen | Biotech Hunter | Biotech Hunter